Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 1

Status

Completed 10Recruiting 8Terminated 4Unknown 3Active not recruiting 2Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4Gastrointestinal 1

Conditions

Breast Neoplasms 989Neoplasms 848Carcinoma, Non-Small-Cell Lung 842Prostatic Neoplasms 527Neoplasm Metastasis 500Leukemia, Myeloid, Acute 488Melanoma 453Colorectal Neoplasms 446Multiple Myeloma 440Lung Neoplasms 419Pancreatic Neoplasms 352Recurrence 350Lymphoma 349Ovarian Neoplasms 341Lymphoma, Non-Hodgkin 327Leukemia 323Leukemia, Lymphocytic, Chronic, B-Cell 301Precursor Cell Lymphoblastic Leukemia-Lymphoma 271Carcinoma, Renal Cell 256Head and Neck Neoplasms 246Brain Neoplasms 243Carcinoma, Hepatocellular 234Squamous Cell Carcinoma of Head and Neck 231Glioblastoma 231Myelodysplastic Syndromes 229Lymphoma, Large B-Cell, Diffuse 228Lymphoma, Follicular 219Colonic Neoplasms 191Stomach Neoplasms 182Rectal Neoplasms 175

Interventions

Fulvestrant 2tusamitamab ravtansine 1palbociclib 1nirogacestat 1exemestane 1Tamoxifen 1Letrozole 1Gemcitabine 1Docetaxel 1Capecitabine 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Interventional × Breast Cancer Metastatic × Clear all
NCT04059484 2026-02-24

AMEERA-3

Sanofi

Phase 2 Terminated
367 enrolled 30 charts
Breast

Breast Cancer Metastatic

NCT04659603 2025-10-01

CARMEN-BT01

Sanofi

Phase 2 Terminated
50 enrolled 20 charts
BreastGastrointestinal

Breast Cancer Metastatic

NCT03322215 2024-03-08

PASIPHAE

Karolinska University Hospital

Phase 2 Terminated
42 enrolled
Breast

Breast Cancer Metastatic

NCT01876251 2019-03-15

A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast Cancer

Pfizer

Phase 1 Terminated
30 enrolled 29 charts
Breast

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡